Loading this company
Quest Diagnostics Incorporated
DGXPrices in USD
TickerWorth ScoreC51/100
What we think
Priced within our range of $99.27 to $327.21.
Price
$234.00USD down −$1.00 (−0.43%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$99.27–$327.21
What the price needs: revenue growth of 6.2%/yr for 5 years (our model assumes 5.9%).
Led by discounted cash flow (DCF) · Steady cash-flow business
Price $234.00Priced · Prices are delayed.
Is it a good business?
- Valuation67 out of 100
- Growth100 out of 100
- Financial health67 out of 100
- Dividend75 out of 100
- Past performance100 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$251.40 across 15 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It operates in the Diagnostics & Research industry (Healthcare sector), headquartered in United States. The company employs roughly 46,000 people.
Key stats
52-week range$171.18–$248.84
- Open
- $234.40
- Day high
- $235.99
- Day low
- $233.84
- Previous close
- $235.00
- Volume
- 43,513 · 0.04× avg
- Average volume
- 1,050,817
- Market cap
- $25,827,366,912.00
- P/E (TTM)
- 24.84
- Earnings per share
- $9.42
- Beta
- 0.54
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Changed leadership or its board
- Reported quarterly or annual results
- Reported shareholder vote results
- Signed a material agreement
- Disclosed another material event
- Reported quarterly or annual results
- Changed leadership or its board
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Davis J. E.Open-market sale · $2,427,200.00
- PREVOZNIK MICHAEL EOption exercise ·
Not investment advice. TickerWorth Score is a model output.